AI-generated summary
The authors report a randomized controlled trial of 52 diabetic patients with xerostomia, comparing diode laser photobiomodulation with no active treatment over 12 weeks. The test group showed significant increases in salivary flow and lower xerostomia symptom scores, while the control group showed little change. The authors suggest the approach might be effective and safe, though the abstract does not describe long-term follow-up.
- Participants
- 52
- Who or what was studied
- Diabetic patients experiencing xerostomia (type II diabetes)
- Wavelengths
- 980 nm
- Limits stated in the abstract
- The abstract does not report long-term follow-up or the details of safety assessment, and the authors frame the conclusion with the hedge 'might be'.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 980 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Control group, Laser, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.